Shelton Capital Management Arrowhead Pharmaceuticals, Inc. Transaction History

Shelton Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$28.0 - $40.56 $154,700 - $224,094	5,525 New	5,525 $224,000
Q2 2022 Aug 11, 2022	SELL	$27.79 - $50.61 $153,539 - $279,620	-5,525 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$58.09 - $82.51 $14,638 - $20,792	-252 Reduced 4.36%	5,525 $366,000
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $11,130 - $21,683	-254 Reduced 4.21%	5,777 $443,000
Q2 2020 Aug 12, 2020	BUY	$26.12 - $43.27 $157,529 - $260,961	6,031 New	6,031 $260,000

294

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.